| |
|
|
|
Citius Pharmaceuticals Inc.  
|
|
1.6 0 (0%) |
10-17 15:59 |
|
Open: |
1.59 |
Pre close: |
1.6 |
Target:
|
2.42
|
|
High: |
1.71 |
Low: |
1.571 |
Resistance:
|
2.07
2.52
|
|
Volume: |
68,062 |
Market Cap: |
26M |
Support:
|
1.35
1.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.65
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
1.72  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.05 |
Stochastic Oscillator |
%K(14,3):
|
4.63 |
|
MA(250): |
2.98 |
%D(3): |
9.32 |
|
Average Volume(K) |
3-Month: |
24178
|
52-Week |
High:
|
5.49 |
|
10-Days: |
7954 |
Low: |
1.12 |
|
RSI |
RSI(14):
|
44.49 |
Change(%): |
-42.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-76.6 |
Shares Out. (M) |
16.20 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-56.1 |
Shares Float (M) |
11.90 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
30.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
86 |
|
Book Value (p.s.) |
1.090 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.24 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.82 |
P/CF |
-2.12 |
|
|
|
|
|
|
